FECS DF
Alternative Names: 3D-F; FECS-DF - S. Biomedics; FECSDF; FECSDF - Clusters of Autologous Dermal FibroblastsLatest Information Update: 28 Aug 2023
Price :
$50 *
At a glance
- Originator S.Biomedics
- Class Fibroblast cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Facial wrinkles
Most Recent Events
- 21 Jun 2023 Phase-I/II clinical trials in Facial wrinkles in South Korea (Intradermal) (NCT04818203) (S. Biomedics pipeline, June 2023)